Citizen, Fossil develop wristwatch able to receive data

Citizen, Fossil develop wristwatch able to receive data

TOKYO, Japan - Citizen Watch Co. and U.S. watchmaker Fossil Inc. have started production of Wrist Net (shown) -- a wristwatch jointly developed by the two companies for the North American market and capable of receiving news, weather and other information, the Japanese watchmaker said Jan. 21. (Kyodo)

  • Product Code
  • ILEA000022998
  • Registered date
  • 2004/1/21 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1228 × 1545 pixel
  • Resolution
  • 72 dpi
  • Deployment size
  • 147.85(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Watchdog accuses bank of sharing info with brokerage affiliates

    Watchdog accuses bank of sharing info with brokerage affiliates

    Photo taken on June 7, 2024, shows Mitsubishi UFJ Financial Group Inc.'s headquarters in Tokyo. Japan's securities watchdog is expected to call for the Financial Services Agency to punish a bank and two brokerage firms operating under the group over allegations they shared confidential information about client companies without obtaining permission.

      Sompo CEO to step down over Bigmotor insurance fraud scandal

      TOKYO, Japan, Jan. 26 Kyodo - Major Japanese insurance firm Sompo Holdings Inc. CEO Kengo Sakurada holds a press conference in Tokyo on Jan. 26, 2024, to announce he will step down at the end of March to take responsibility for the company's involvement in used car dealer Bigmotor Co.'s insurance fraud scandal. (Kyodo)

        Maglev train tunnel work site shown to media

        KAWASAKI, Japan Kyodo - Video taken on Jan. 15, 2024, shows a maglev train tunnel work site in Kawasaki near Tokyo, shown to the media ahead of full-fledged drilling beginning around September. Central Japan Railway Co.'s Linear Chuo Shinkansen bullet train service will link between Tokyo and Osaka for about one hour. (Kyodo)

          [Breaking News] Nikkei ends at nearly 34-year high

          TOKYO, Japan Kyodo - A roadside financial data screen in Tokyo on Jan. 10, 2024, shows the 225-issue Nikkei Stock Average closing at 34,441.72, marking its highest close since February 1990, when Japan was in the midst of an asset price bubble. (Kyodo)

            Daihatsu to stop all vehicle shipments over improper safety testing

            TOKYO, Dec. 20 Kyodo - Daihatsu Motor Co. said Wednesday it will stop all shipments at home and abroad after the Toyota Motor Corp. subsidiary found most of its car models were affected by improper vehicle safety tests. The move comes after the minivehicle maker acknowledged earlier this year data-rigging in collision tests for six of its models, including those sold in Thailand and Malaysia. A third-party panel it has set up identified 174 new counts of misconduct across 25 vehicle test items in addition to those already discovered, with the oldest one dating back to 1989, Daihatsu said, adding that it reported the findings to the transport ministry. (Kyodo)
              U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

              U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

              Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                    Boeing 787

                    Boeing 787

                    File photo taken in June 2017 at Narita airport near Tokyo shows a Boeing 787 airplane operated by Japan Airlines Co. The U.S. aircraft manufacturer said it will cut the production of the jetliner by 50 percent, to seven per month by 2022 from 14 a month at present, in response to contraction in demand due to the coronavirus pandemic. (Kyodo) ==Kyodo
                      U.S. stock market rebound

                      U.S. stock market rebound

                      A financial data screen in Tokyo on March 25, 2020, shows the Dow Jones Industrial Average posting its largest one-day point gain in history in New York overnight on hopes for a coronavirus stimulus package. (Kyodo) ==Kyodo